Physician
South Texas Allergy & Asthma Medical Professionals PLLC
South Texas Allergy & Asthma Medical Professionals PLLC was paid $2.57M by Medicaid between Oct 2020 and Dec 2024, across 43 billing codes. Its largest line is J2357, Injection, omalizumab, 5 mg — 27% of everything it billed.
33Billing provider infoSOUTH TEXAS ALLERGY & ASTHMA MEDICAL PROFESSIONALS PLLC
SAN ANTONIO, TX 78251
SAN ANTONIO, TX 78251
33aNPI1689085854assigned 05/09/2014
33bProvider typeAllergy & Immunology Physician
28Total paid$2.57M
24GClaims42,990
24DCodes billed43
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Texas
Rank by total paid#8 of 62
Median peer was paid$91K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 540 | $28K | |
| 2021 | 9,464 | $343K | |
| 2022 | 7,171 | $417K | |
| 2023 | 13,652 | $991K | |
| 2024incomplete | 12,163 | $795K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | 27% | 349 | 255 | $697K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 26% | 2,408 | 2,303 | $669K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 7,441 | 7,166 | $361K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 12% | 1,044 | 378 | $296K |
| 96401 | 5.0% | 1,495 | 1,108 | $129K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.1% | 986 | 967 | $79K |
| 95117 | 2.6% | 7,671 | 3,852 | $66K | |
| 94010 | 2.1% | 2,327 | 2,214 | $53K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.4% | 294 | 290 | $36K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 1,844 | 1,671 | $35K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 713 | 697 | $24K |
| 99000 | <1% | 1,998 | 1,596 | $18K |
31 more codes
| 94060 | <1% | 449 | $16K | |
| 95115 | <1% | 1,658 | $12K | |
| 0071A | <1% | 270 | $10K | |
| 94375 | <1% | 329 | $10K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 123 | $9K |
| 0072A | <1% | 182 | $7K | |
| 99358 | Prolong nursin fac eval 15m | <1% | 127 | $7K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 427 | $6K |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 2,503 | $5K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 111 | $4K |
| 0001A | <1% | 122 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 60 | $4K |
| 0002A | <1% | 78 | $3K | |
| 86328 | <1% | 107 | $3K | |
| 87428 | <1% | 37 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 70 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 154 | $2K |
| 95012 | <1% | 97 | $2K | |
| 98960 | <1% | 216 | $1K | |
| 94728 | <1% | 13 | $427.40 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 373 | $333.69 |
| 0004A | <1% | 16 | $280.00 | |
| 94760 | <1% | 3,272 | $143.32 | |
| 96160 | <1% | 1,807 | $139.72 | |
| A4617 | Mouth piece | <1% | 85 | $126.75 |
| 94761 | <1% | 561 | $89.98 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 18 | $70.87 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 395 | $22.66 |
| 94664 | 0% | 444 | $0.00 | |
| 99072 | 0% | 34 | $0.00 | |
| J3590 | Unclassified biologics | 0% | 282 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREYES, JOEL (PRESIDENT/SECRETARY)